Logo image of QS

QUANTUMSCAPE CORP (QS) Stock Fundamental Analysis

NYSE:QS - New York Stock Exchange, Inc. - US74767V1098 - Common Stock - Currency: USD

7.02  +0.22 (+3.24%)

After market: 7 -0.02 (-0.28%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to QS. QS was compared to 81 industry peers in the Automobile Components industry. QS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. QS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

QS had negative earnings in the past year.
QS had a negative operating cash flow in the past year.
QS had negative earnings in each of the past 5 years.
QS had a negative operating cash flow in each of the past 5 years.
QS Yearly Net Income VS EBIT VS OCF VS FCFQS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -500M -1B -1.5B

1.2 Ratios

The Return On Assets of QS (-37.46%) is worse than 93.83% of its industry peers.
Looking at the Return On Equity, with a value of -42.54%, QS is doing worse than 87.65% of the companies in the same industry.
Industry RankSector Rank
ROA -37.46%
ROE -42.54%
ROIC N/A
ROA(3y)-31.23%
ROA(5y)-50.8%
ROE(3y)-35.26%
ROE(5y)-54.03%
ROIC(3y)N/A
ROIC(5y)N/A
QS Yearly ROA, ROE, ROICQS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for QS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QS Yearly Profit, Operating, Gross MarginsQS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, QS has more shares outstanding
The debt/assets ratio for QS is higher compared to a year ago.
QS Yearly Shares OutstandingQS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
QS Yearly Total Debt VS Total AssetsQS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

QS has an Altman-Z score of 10.77. This indicates that QS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 10.77, QS belongs to the top of the industry, outperforming 92.59% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that QS is not too dependend on debt financing.
The Debt to Equity ratio of QS (0.03) is better than 91.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 10.77
ROIC/WACCN/A
WACCN/A
QS Yearly LT Debt VS Equity VS FCFQS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 16.66 indicates that QS has no problem at all paying its short term obligations.
The Current ratio of QS (16.66) is better than 98.77% of its industry peers.
A Quick Ratio of 16.66 indicates that QS has no problem at all paying its short term obligations.
The Quick ratio of QS (16.66) is better than 98.77% of its industry peers.
Industry RankSector Rank
Current Ratio 16.66
Quick Ratio 16.66
QS Yearly Current Assets VS Current LiabilitesQS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B

1

3. Growth

3.1 Past

QS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.21%.
EPS 1Y (TTM)5.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, QS will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.80% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.09%
EPS Next 2Y9.28%
EPS Next 3Y16.02%
EPS Next 5Y18.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QS Yearly Revenue VS EstimatesQS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
QS Yearly EPS VS EstimatesQS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

QS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QS Price Earnings VS Forward Price EarningsQS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QS Per share dataQS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

QS's earnings are expected to grow with 16.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.28%
EPS Next 3Y16.02%

0

5. Dividend

5.1 Amount

No dividends for QS!.
Industry RankSector Rank
Dividend Yield N/A

QUANTUMSCAPE CORP

NYSE:QS (7/3/2025, 5:11:07 PM)

After market: 7 -0.02 (-0.28%)

7.02

+0.22 (+3.24%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)07-23 2025-07-23/amc
Inst Owners31.42%
Inst Owner Change6.96%
Ins Owners2.76%
Ins Owner Change6.33%
Market Cap3.92B
Analysts47.5
Price Target5 (-28.77%)
Short Float %16.55%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.21%
Min EPS beat(2)-1.22%
Max EPS beat(2)3.64%
EPS beat(4)1
Avg EPS beat(4)-2.95%
Min EPS beat(4)-7.87%
Max EPS beat(4)3.64%
EPS beat(8)3
Avg EPS beat(8)1.24%
EPS beat(12)3
Avg EPS beat(12)-5.89%
EPS beat(16)3
Avg EPS beat(16)-15.95%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.73%
PT rev (3m)-17.12%
EPS NQ rev (1m)-2.04%
EPS NQ rev (3m)1.64%
EPS NY rev (1m)3.08%
EPS NY rev (3m)-1.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.54
P/tB 3.54
EV/EBITDA N/A
EPS(TTM)-0.91
EYN/A
EPS(NY)-0.76
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS0
BVpS1.98
TBVpS1.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.46%
ROE -42.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.23%
ROA(5y)-50.8%
ROE(3y)-35.26%
ROE(5y)-54.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 74.57%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.66
Quick Ratio 16.66
Altman-Z 10.77
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)275.34%
Cap/Depr(5y)456.26%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y9.09%
EPS Next 2Y9.28%
EPS Next 3Y16.02%
EPS Next 5Y18.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.52%
EBIT Next 3Y14.45%
EBIT Next 5Y15.98%
FCF growth 1Y12.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.07%
OCF growth 3YN/A
OCF growth 5YN/A